ZYMENEX AS has a total of 35 patent applications. Its first patent ever was published in 2000. It filed its patents most often in New Zealand, Canada and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and foods and drinks are SHIRE PHARMACEUTICALS IRELAND LTD, THROMBOGENICS NV and PORTAGE PHARMACEUTICALS LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | New Zealand | 7 | |
#2 | Canada | 5 | |
#3 | WIPO (World Intellectual Property Organization) | 4 | |
#4 | Japan | 3 | |
#5 | Norway | 3 | |
#6 | United States | 3 | |
#7 | South Africa | 3 | |
#8 | Brazil | 2 | |
#9 | China | 2 | |
#10 | EAPO (Eurasian Patent Organization) | 1 | |
#11 | EPO (European Patent Office) | 1 | |
#12 | Hong Kong | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Foods and drinks | |
#4 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Microorganisms | |
#3 | Therapeutic chemical compounds | |
#4 | Enzymes | |
#5 | Peptides | |
#6 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Nilsson Stefan | 23 |
#2 | Fogh Jens | 15 |
#3 | Andersson Claes | 12 |
#4 | Weigelt Cecilia | 11 |
#5 | Hyden Pia | 8 |
#6 | Reuterwall Helena | 7 |
#7 | Moller Christer | 2 |
#8 | Gellerfors Par | 2 |
#9 | Nilsson Stephen | 2 |
#10 | Irani Meher | 1 |
Publication | Filing date | Title |
---|---|---|
CN102834111A | Process for production and purification of recombinant lysosomal alpha-mannosidase | |
CN101410408A | A process for concentration of a polypeptide | |
WO2005094874A1 | Medical use of alpha-mannosidase | |
WO2005073367A1 | Production and purification of recombinant arylsulfatase a |